Pyxis Oncology names Thomas Civik CEO, board chair - PYXS News | RalliesPyxis Oncology names Thomas Civik CEO, board chair
P
PYXS• Pyxis Oncology names new CEO and board chair
- Pyxis Oncology named Thomas Civik chief executive officer, effective Sept. 4, 2026.
- Civik also takes over as chairman; he had served as interim CEO since February 2026.
- Co-founder John Flavin moved from chairman to lead independent director.
- Civik previously led Five Prime Therapeutics until its $1.9 billion sale to Amgen in 2021.
•
